My true feelings after taking Ribocil/Kaillon for two years

Ribociclib is a selective CDK4/6 inhibitor that is often used in combination with endocrine therapy for the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. During the actual medication process, what many patients are most concerned about is not the cold experimental data, but the real feelings after long-term use. The two-year medication cycle means that patients not only have to face the challenges of the tumor disease itself, but also go through the physical and mental adaptation process brought about by the medication.

From a treatment perspective, many patients will feel that their disease is controlled to a certain extent when using reboxiclib combined with an aromatase inhibitor or fulvestrant, and imaging examinations show that their condition is stable and their quality of life has improved. This is the positive meaning brought about by long-term adherence to medication. But at the same time, patients will experience some accompanying discomfort over the course of two years. Common experiences include fatigue, mild gastrointestinal discomfort, and hematological fluctuations, such as neutropenia. Some patients describe that this change does not appear immediately, but gradually accumulates during long-term medication, requiring regular monitoring to ensure safety.

On a psychological level, adhering to medication for two years is a test for patients. The habit of taking medication regularly every day and stopping medication periodically requires good self-discipline. Many patients reported that their initial concern was whether they could endure the side effects for a long time, but as they gradually adapted, they experienced more of integrating it into their daily routine and treating it like a chronic disease. The support of family members and communication between doctors and patients are also important motivations for long-term persistence of patients.

Therefore, overall, the true experience of taking Riboxil for two years is often “effects and side effects coexist.” On the one hand, it helps patients extend their progression-free survival and give them more time to spend with their families; on the other hand, it requires patients to continuously monitor their physical condition and face periodic side effects management.

Reference materials:https://us.kisqali.com/